Co-expression of CXCL8 and HIF-1α is associated with metastasis and poor prognosis in hepatocellular carcinoma
Metrics: PDF 1608 views | HTML 1154 views | ?
Xian-Peng Li1,*, Xiao-Yu Yang2,*, Ewelina Biskup3, Jiang Zhou1, Hong-Liang Li1, Yi-Feng Wu4, Ming-Liang Chen4 and Feng Xu1
1 Division of Gastroenterology and Hepatology, Yinzhou Hospital Affiliated to Medical School of Ningbo University, Ningbo, China
2 Division of Special Treatment II, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China
3 Department of Oncology, University Hospital of Basel, Basel, Switzerland
4 Division of Hepatobiliary Surgery, Yinzhou Hospital Affiliated to Medical School of Ningbo University, Ningbo, China
* These authors contributed equally to this study and should be considered as co-first authors
Feng Xu, email:
Keywords: IL-8, cytokines, migration, hypoxia, metastasis, HCC
Received: February 04, 2015 Accepted: May 25, 2015 Published: June 10, 2015
Hypoxia inducible factor-1α (HIF-1α), induces cytokines such as CXCL8 and tumor dissemination, chemo- and radio-resistance. We analyzed correlation between HIF-1α and CXCL8 levels, tumor characteristics and overall survival in 102 hepatocellular carcinoma (HCC) patients. Levels of HIF-1α and CXCL8 were increased in HCC tissues and cell lines. Patients with high levels of HIF-1α and CXCL8 had worse outcome and poorer prognosis than those with lower levels. Co-overexpression of HIF-1α and CXCL8 was an independent negative prognostic factor for overall and disease-free survival. HIF-1α silencing and CXCL8 siRNA decreased migration under hypoxic conditions in vitro. Hypoxia-induced activation of AKT/mTOR/STAT3 pathways was reversed by depletion of CXCL8. We conclude that HIF-1α and CXCL8 induce HCC progression and metastasis, associated with activation of AKT/mTOR/STAT3. Co-expression of HIF-1α and CXCL8 is a prognostic marker and a potential therapeutic target in HCC.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.